Related Experiment Video
Updated: Jun 1, 2025

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization
Published on: August 4, 2023
Carbapenem-resistant Acinetobacter baumannii and Ventilator-associated Pneumonia; Epidemiology, Risk Factors, and
Malihe Kazemi Najafabadi1, Rasool Soltani1,2
1Department of Clinical Pharmacy and Pharmacy Practice, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract:
Acinetobacter baumannii is one of the primary pathogens responsible for healthcare-associated infections. It is related to high rates of morbidity and mortality globally, mainly because of its high capacity to develop resistance to antimicrobials. Nowadays, carbapenem-resistant A. baumannii (CRAB) has increased and represents a significant concern among carbapenem-resistant organisms. It is also a key pathogen associated with ventilator-associated pneumonia. CRAB was placed on the critical group of the universal priority list of the World Health Organization for antibiotic-resistant bacteria, to mention the importance of research development and the urgency of new antibiotics. Patients with severe CRAB infections currently face significant treatment challenges. Some approaches have been taken to deal with CRAB, such as combination therapy and the synergistic effect of certain antibiotics, but the best antibiotic regimen is still unknown. In this narrative review, we attempt to clarify the issues, including epidemiology, risk factors, and current treatment options for CRAB.
Insights
Carbapenem-resistant Acinetobacter baumannii (CRAB) causes severe healthcare infections globally. This review explores CRAB epidemiology, risk factors, and treatment challenges, highlighting the urgent need for new antibiotics.
Area of Science:
- Infectious Diseases
- Microbiology
- Antimicrobial Resistance
Background:
- Acinetobacter baumannii is a major cause of healthcare-associated infections, linked to high morbidity and mortality.
- The rise of carbapenem-resistant Acinetobacter baumannii (CRAB) is a significant global health concern.
- CRAB is a critical priority pathogen on the World Health Organization's list, emphasizing the need for new treatments.
Purpose of the Study:
- To review the epidemiology of CRAB infections.
- To identify risk factors associated with CRAB acquisition and development.
- To summarize current treatment strategies and challenges for CRAB.
Main Methods:
- This study is a narrative review.
- Literature search was conducted on CRAB, focusing on epidemiology, risk factors, and treatment.
- Information was synthesized to provide a comprehensive overview.
Main Results:
- CRAB infections are increasing, posing significant treatment challenges.
- Combination therapies and synergistic antibiotic effects are being explored but optimal regimens remain unclear.
- Understanding risk factors is crucial for infection control and prevention.
Conclusions:
- CRAB represents a critical threat in healthcare settings, demanding urgent attention.
- Further research is essential to develop effective treatment strategies and novel antibiotics.
- Effective management requires a multifaceted approach including infection control and optimized therapeutic regimens.
More Related Videos
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia III: Complications and Assessment